Delivery Order SPE2DR25D2104-SPE2DR26F3PHK
- Not listed
- The Defense Logistics Agency awarded a $1,278.64 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of CAPLYTA 42 mg capsules (30-count units). AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was selected through competitive procurement with no set-aside designation. The delivery order has an ultimate completion date of July 23, 2025, with performance at the contractor's Conshohocken...
- The Defense Logistics Agency awarded a delivery order valued at $16,800.83 to AmerisourceBergen Drug Corp for the supply of CAPLYTA 42 mg capsules (30-count units) under a firm fixed-price contract. The award, issued on November 14, 2025, with an ultimate completion date of November 17, 2025, represents a non-set-aside competitive award. AmerisourceBergen will perform this delivery order from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $13,827.40 to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of CAPLYTA 42 MG capsules (30-count units). The contract utilizes firm fixed-price pricing with no set-aside designation, indicating competitive award to this established pharmaceutical distributor. Performance will be executed from AmerisourceBergen's Conshohocken, Pennsylvania location, with completion scheduled for September 9, 2025. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of CAPLYTA 42 mg capsules (30-unit packages) with a ceiling value of $2,971.27 under firm fixed pricing. The award, issued on November 7, 2025, with an ultimate completion date of November 10, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of CAPLYTA 42 mg capsules (30-count units) under a firm fixed-price contract with a ceiling value of $5,766.76. This non-set-aside award was issued on September 15, 2025, with an ultimate completion date of September 16, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location in the...
- On July 29, 2025, the Defense Logistics Agency awarded a delivery order valued at $7,172.24 to AmerisourceBergen Drug Corp for CAPLYTA 42 mg capsules (30-count units). This firm fixed price delivery order, with an ultimate completion date of July 30, 2025, represents a non-set-aside competitive award supporting federal medical procurement. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company operates as a major pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of CAPLYTA 42 mg capsules (30-count units) with a ceiling value of $4,686.46. This firm fixed-price delivery order, awarded on August 25, 2025, with an ultimate completion date of August 26, 2025, represents a non-competitive set-aside contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,543.88 to AmerisourceBergen Drug Corp for the supply of CAPLYTA 42 mg capsules (30-count units) under a firm fixed-price contract. The award was made on September 22, 2025, with an ultimate completion date of September 23, 2025, and represents a non-set-aside competitive procurement. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 16, 2025, for the supply of CAPLYTA 42 mg capsules in a quantity of 30 units. This firm fixed price delivery order, valued at $29,358.50 with an ultimate completion date of September 17, 2025, represents a non-set-aside competitive award. The contract will be performed at the awardee's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of CAPLYTA 42 mg capsules (30-count units) valued at $3,348.66 under a firm fixed-price contract. This is a non-set-aside competitive award with an ultimate completion date of August 4, 2025, with performance to be fulfilled at the vendor's Conshohocken, Pennsylvania facility. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3PHKDelivery Order
The Defense Logistics Agency awarded a $6,535.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of CAPLYTA 42 mg capsules (30-count units). The contract, which is not set-aside, is scheduled for completion by November 19, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), which carries a maximum value of $999,999,999 and extends through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. The company's extensive portfolio of DLA contracts demonstrates its capability to fulfill federal medical supply requirements through open competition, with past awards involving specialty medications, vaccines, and medical devices across multiple therapeutic domains. The Pharmaceutical Prime Vendor Global Program contracts through which this award is made support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, positioning AmerisourceBergen as a key supplier of essential medications to the federal government.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.5k | 11/18/25 |